88 research outputs found
Cancer patients enrolled in a smoking cessation clinical trial: characteristics and correlates of smoking rate and nicotine dependence
This is the final version. Available on open access from Hindawi Publishing Corporation via the DOI in this recordIntroduction: A substantial proportion of cancer patients continue to smoke after their
diagnosis but relatively few studies have evaluated correlates of nicotine dependence and
smoking rate in this population, which could help guide smoking cessation interventions.
Aim: This study evaluated correlates of smoking rate and nicotine dependence in a
sample of 207 cancer patients.
Methods: A cross-sectional analysis using multiple linear regression evaluated disease,
demographic, affective, and tobacco-seeking correlates of smoking rate and nicotine dependence.
Smoking rate was assessed using a timeline follow-back assessment of cigarettes smoked per
day. The Fagerström Test for Nicotine Dependence measured levels of nicotine dependence.
Results: The primary analysis, using multiple linear regression predicting nicotine
dependence, showed an association with smoking to alleviate a sense of addiction from the
Reasons for Smoking Scale and tobacco-seeking behavior from the Concurrent Choice Task (p <
.05), but not with affect measured by the HADS and PANAS (p > .05). Multiple linear
regression predicting smoking rates prior to pre-quit visit also showed an association with
smoking to alleviate addiction (p < .05). ANOVA showed that Caucasian participants reported
greater rates of smoking compared to other reported races.
Conclusions: The results suggest that behavioral smoking cessation interventions that
focus on helping patients to manage tobacco-seeking behavior, rather than mood management
interventions, could help cancer patients to quit smoking, as this data could be used to help tailor
treatments for this population
Cigarette smoking and depression comorbidity: systematic review and proposed theoretical model
This is the author accepted manuscript. The final version is available from the publisher via the DOI in this record.BACKGROUND AND AIMS: Despite decades of research on co-occurring smoking and depression, cessation rates remain consistently lower for depressed smokers than for smokers in the general population, highlighting the need for theory-driven models of smoking and depression. This paper provides a systematic review with a particular focus upon psychological states that disproportionately motivate smoking in depression, and frame an incentive learning theory account of smoking-depression co-occurrence. METHODS: We searched PubMed, Scopus, PsychINFO and CINAHL to December 2014, which yielded 852 papers. Using pre-established eligibility criteria, we identified papers focused on clinical issues and motivational mechanisms underlying smoking in established, adult smokers (i.e. maintenance, quit attempts and cessation/relapse) with elevated symptoms of depression. Two reviewers determined independently whether papers met review criteria. We included 297 papers in qualitative synthesis. RESULTS: Our review identified three primary mechanisms that underlie persistent smoking among depressed smokers: low positive affect, high negative affect and cognitive impairment. We propose a novel application of incentive learning theory which posits that depressed smokers experience greater increases in the expected value of smoking in the face of these three motivational states, which promotes goal-directed choice of smoking behavior over alternative actions. CONCLUSIONS: The incentive learning theory accounts for current evidence on how depression primes smoking behavior and provides a unique framework for conceptualizing psychological mechanisms of smoking maintenance among depressed smokers. Treatment should focus upon correcting adverse internal states and beliefs about the high value of smoking in those states to improve cessation outcomes for depressed smokers.This work is supported by the National Cancer Instituteand National Institute on Drug Abuse of the UnitedStates National Institutes of Health (Grant NumbersF32DA036947 and R01CA184211). J.W.C. is supportedby Merit Review Award 101CX00056 from the US Depart-ment of Veterans Affairs
Negative mood reverses devaluation of goal-directed drug-seeking favouring an incentive learning account of drug dependence
Recommended from our members
Genome-Wide Meta-Analyses of Smoking Behaviors in African Americans
The identification and exploration of genetic loci that influence smoking behaviors have been conducted primarily in populations of the European ancestry. Here we report results of the first genome-wide association study meta-analysis of smoking behavior in African Americans in the Study of Tobacco in Minority Populations Genetics Consortium (n=32 389). We identified one non-coding single-nucleotide polymorphism (SNP; rs2036527[A]) on chromosome 15q25.1 associated with smoking quantity (cigarettes per day), which exceeded genome-wide significance (=0.040, s.e.=0.007, P=1.84 × 10). This variant is present in the 5′-distal enhancer region of the CHRNA5 gene and defines the primary index signal reported in studies of the European ancestry. No other SNP reached genome-wide significance for smoking initiation (SI, ever vs never smoking), age of SI, or smoking cessation (SC, former vs current smoking). Informative associations that approached genome-wide significance included three modestly correlated variants, at 15q25.1 within PSMA4, CHRNA5 and CHRNA3 for smoking quantity, which are associated with a second signal previously reported in studies in European ancestry populations, and a signal represented by three SNPs in the SPOCK2 gene on chr10q22.1. The association at 15q25.1 confirms this region as an important susceptibility locus for smoking quantity in men and women of African ancestry. Larger studies will be needed to validate the suggestive loci that did not reach genome-wide significance and further elucidate the contribution of genetic variation to disparities in cigarette consumption, SC and smoking-attributable disease between African Americans and European Americans
Major Depression Is a Risk Factor for Shorter Time to First Cigarette Irrespective of the Number of Cigarettes Smoked Per Day: Evidence From a National Population Health Survey
Article deposited according to Oxford Open Self-Archiving policy: http://www.oxfordjournals.org/oxfordopen/policies.html, January 12, 2012.YesFunding provided by the Open Access Authors Fund
Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment?
Smoking as a product of gene–environment interaction
A strong hereditary influence on smoking has been demonstrated. As one of the candidate genes in relation to smoking, the serotonin transporter gene (5-HTTLPR) has been suggested, however with conflicting results. In recent studies, it has been shown that genotypic and environmental (G*E) factors interact in the shaping of a variety of phenotypic expressions. The objective of the present study was to investigate the interaction between a variation in the 5-HTTLPR and family environment in relation to smoking habits, nicotine dependence, and nicotine and cotinine levels in hair samples
Influencia de fatores psicossociais na cessacao do tabagismo: evidencias longitudinais no Estudo Pro-Saude
Serious mental illness and smoking cessation
Smoking rates among individuals with severe mental illness are significantly higher than in the general population. Contrary to common perception, individuals with severe mental illness have been shown to be motivated to quit smoking. This paper discusses and synthesises literature on smoking among individuals with severe mental illness and contributes to the debate about the significant role mental health professionals can play in targeting the effective cessation therapies towards smokers with severe mental illness. Severe mental illnesses include schizophrenia, paranoid and other psychotic disorders, psychotic depression, bipolar affective disorder, major depression
- …